Książki

This is the seventh monograph in the series Progress and Controversies in Oncologic Urology (PACIOU). Containing contributions from experts from around the globe, this book provides the most up-to-date information available on the mechanisms and treatment of prostate cancer and male sexual dysfunction. Highlighting the relationship between research results and the clinical practice, the discussions include the diagnosis and therapy of benign prostate cancer, diagnosis and outcomes in locally confined prostate cancer, epidemiology, risk factors, renal cancer, and the results of phase I and phase II trials of new drug treatments.

Prostate & Renal Cancer Benign Prostatic Hyperplasia

SEXUAL FUNCTION: MECHANISMS AND TREATMENT

Sexual Health of the Aging Male, E.J.H. Meuleman

Determinants of Sexual Function in the Aging Male, J.L.H.R. Bosch

The Impact of Radical Prostatectomy and Primary Radiotherapy for Localized Prostate Cancer on Quality of Life, M.L. Essink-Bot, I.J. Korfage, H.J. de Koning

Sexual Function Before and After Radical Retropubic Prostatectomy: A Prospective Analysis, G.R. Dohle, Y.D. Dubbelman, S.F.M. Broersen, M. Wildhagen and F.H. Schroeder

Effects of Endocrine Treatment - Can Libido and Sexual Function be Preserved? P. Iversen

Oral Therapy, H. Porst

Intracavernosal Injection Therapy for Erectile Dysfunction: An Update, F. Montorsi

Mechanisms and Prevention of Erectile Dysfunction after Radiotherapy for Prostate Cancer, L. Incrocci



BENIGN PROSTATE HYPERPLASIA: PROGRESS AND CONTROVERSY IN DIAGNOSIS AND THERAPY

Evaluation and Management of Lower Urinary Tract Symptoms Related to Benign Prostate Disease: The Contribution of the International Continence Society (ICS)- 'Benign Prostatic Hyperplasia' Study, J.L. Donovan

Distinguishing Nocturnal Polyuria from Benign Prostatic Hyperplasia-Related Nocturnia: Simple Algorithms for General and Urological Practice, M.H. Blanker and J. Prins

Practical Application of Non-Invasive Tests to Grade Outflow Obstruction and Bladder Contractility: The End of Classical Urodynamics? J.J.M. Pel, J.W.M.C. Huang Foen Chung, and R. van Mastrigt

Screening for Prostate Cancer within the Benign Prostatic Hypertrophy Population: Current Evidence and Future Directions, M.R. Cooperberg and P.R. Carroll

Androgen Supplementation in Older Men: What is the Impact on PSA, Prostate Growth, and Lower Urinary Tract Symptoms? L.J.G. Gooren and M. Bunck



BASIC RESEARCH ON PROSTATE CANCER

Diagnosis, Classification, and Therapy Development for Human Prostate Cancer Using Biochip Technologies and Post-Genomic Era Molecular Medicine, O.P. Kallioniemi, M. Wolf, L. Bubendorf and S. Mousses

Candidate Genetic Markers and Therapeutic Targets in Hereditary and Sporadic Prostate Cancer, P. Berthon

Basic Research on Prostate Cancer : Signal Transduction, Z. Culig

Stem Cells and Differentiation in Human Prostate Cancer, J.R. Masters, T.N. Alam, C.L. Foley, I. Laczko and D.L. Hudson

Role of the Stromal Micro Environment in Carcinogenesis of the Prostate, G.R. Cunha, S.W. Hayward, Y.Z. Wang and W.A. Ricke

Prostate Cancer Xenograft Models, J.C. Romijn

Hormonal Regulation of Prostate Cancer, C.A. Berrvoets, A. Umar and A.O. Brinkmann

Profiling Protein Interactions in Angiogenesis, R. Pasqualini and W. Arap



TRANSLATIONAL RESEARCH INPROSTATE CANCER: WHAT IS CLOSE TO CLINICAL PRACTICE

The Immunotherapy of Prostate Cancer, G. Dalgleish

Prognostic Tissue Factors for Prostate Cancer: Recent Developments and Pitfalls, M.A. Noordzij

Diagnostic Markers for Prostate Cancer Detected in Serum, Plasma or Blood; Prostate-Specific Antigen-Forms and Human Kallikrein 2 (hK2) for Early Detection and Staging, H. Huland, A. Haese and H. Lilja

Expected Impact of New Technologies on Prostate Cancer Research, G. Jenster



DIAGNOSIS AND OUTCOME IN LOCALLY CONFINED PROSTATE CANCER

Predictive Algorithms and their Clinical Relevance, M. Graefen and H. Huland

Defining the Proper 'Window of Opportunity' in the Early Detection of Prostate Cancer, A.N. Vis

Screening for Prostate Cancer: Views from the UK and the Rest of the World, F.C. Hamdy

Outcome after Radical Prostatectomy - How Predictive are Biopsy versus Radical Prostatectomy Specimens? L. Boccon-Gibod, L. Nicolas, O. Dumonceau, V. Ravery, M. Toublanc, Li Boccon-Gibod



PROSTATE CANCER, EPIDEMIOLOGY, RISK FACTORS, AND OUTCOMES PER TREATMENT

A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer, H. Haggman,

Prostate Cancer Mortality and Screening, S. Oliver

Expectant Management with Selective Delayed Intervention for Favorable Risk Prostate Cancer, L. Klotz

Is Cure of Prostate Cancer Possible in those in Whom it is Necessary, P.C. Walsh



RENAL CANCER

Modern Molecular Classification of Renal Cell Carcinoma: Relevance for Urologists? F. Algaba

Prognostic Factors for Renal Cell Carcinoma, Z. Kirkali, E. Tuzel and M. Ugur Mungan

High-Tech Diagnostic Procedures in RCC: Promise and Practice, G.P. Krestin and F. Cademartiri

Technical and Surgical Progress in Organ-Sparing Approaches for RCC,J. Hoang-Boam and P. Alken

Surgery for Renal Cell Carcinoma: The Case for Open Surgery, D. Jacqmin

Laparoscopic Partial Nephrectomy: Pro, J. Rassweiler and S.K.H. Yip

Laparoscopic Radical and Nephrectomy - Pro, D. Teber, V. Moraga, S. Yip, Y. Dekel, T. Frede, O. Seeman and J. Rassweiler

Clinical Research Avenues in Metastactic Renal Cell Carcinoma, G.H.J. Mickisch



PROSTATE CANCER, LOCALLY ADVANCED AND NODE POSITIVE

Diet and Prostate Cancer, K. Griffith, L.J. Denis and A. Turkes

Determinants of Prostate Cancer-Specific Survival Following Radiation Therapy for Patients with Clinically Localized Prostate Cancer, A.V. D'Amico

Use of Adjuvant Hormonal Therapy with Radical Prostatectomy in N+ Disease: Rationale and Contribution to Outcome, R.P Myers, E.J. Bergstralh, J.M. Slezak, G.M. Farrow, M.M. Lieber, M.L. Blute and H. Zincke



ADVANCED PROSTATE CANCER

Side Effects of Endocrine Treatment: Role of Duration of Treatment, D. Kirk

Chemotherapy for the Treatment of Hormone-Refractory Prostate Cancer: Evaluating New Targets Based on Apoptotic Pathways, D.P. Petrylak

The Role of Biphosphonates in Prostatic Cancer, D.S. Ernst

Direct from the Pipeline: Results of Phase I and II Studies of New Drugs, C. Sternberg

Chemotherapy in the Management of Prostate Cancer, C. Logothetis and R.E. Millikan